[
  {
    "ts": null,
    "headline": "Stock Market Today, Jan. 7: Banks Slide as Stock Rally Slows",
    "summary": "Today, Jan. 7, 2026, a slide in major banks left financials reeling even as AI-fueled tech kept the Nasdaq in the green.",
    "url": "https://finnhub.io/api/news?id=3a4958a989176fda69674f592270f04448f766a458060854233c4f619d79f784",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767828010,
      "headline": "Stock Market Today, Jan. 7: Banks Slide as Stock Rally Slows",
      "id": 138032845,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Today, Jan. 7, 2026, a slide in major banks left financials reeling even as AI-fueled tech kept the Nasdaq in the green.",
      "url": "https://finnhub.io/api/news?id=3a4958a989176fda69674f592270f04448f766a458060854233c4f619d79f784"
    }
  },
  {
    "ts": null,
    "headline": "Bank of America Joins JPMorgan, Citi, Morgan Stanley By Recommending Bitcoin Portfolio Allocation",
    "summary": "Bank of America Corp. (NYSE:BAC) will allow more than 15,000 Merrill and Private Bank advisers to proactively recommend four spot Bitcoin (CRYPTO: BTC) ETFs starting Jan. 5, formally opening Bitcoin access across its wealth platform. Big Four Banks Now All...",
    "url": "https://finnhub.io/api/news?id=4c74830baefc7ce0772c87f0258d3348f8e5ae1bccd2c3da8883e6d93989015d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767826865,
      "headline": "Bank of America Joins JPMorgan, Citi, Morgan Stanley By Recommending Bitcoin Portfolio Allocation",
      "id": 138033015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Bank of America Corp. (NYSE:BAC) will allow more than 15,000 Merrill and Private Bank advisers to proactively recommend four spot Bitcoin (CRYPTO: BTC) ETFs starting Jan. 5, formally opening Bitcoin access across its wealth platform. Big Four Banks Now All...",
      "url": "https://finnhub.io/api/news?id=4c74830baefc7ce0772c87f0258d3348f8e5ae1bccd2c3da8883e6d93989015d"
    }
  },
  {
    "ts": null,
    "headline": "Chase to become new issuer of Apple Card",
    "summary": "WILMINGTON, Del., January 07, 2026--Today, Apple and Chase announced that Chase will become the new issuer of Apple Card, with an expected transition in approximately 24 months.",
    "url": "https://finnhub.io/api/news?id=5892e72936ded59e6d6624d5bb62da4ff8219360da2dc43b35305feb8b0357ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767826140,
      "headline": "Chase to become new issuer of Apple Card",
      "id": 138032865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del., January 07, 2026--Today, Apple and Chase announced that Chase will become the new issuer of Apple Card, with an expected transition in approximately 24 months.",
      "url": "https://finnhub.io/api/news?id=5892e72936ded59e6d6624d5bb62da4ff8219360da2dc43b35305feb8b0357ab"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Jones Slid From Peaks Amid Sell-Off in Old Economy Sectors, Mounting Geopolitical Crisis",
    "summary": "US equity indexes closed mixed on Wednesday, with the S&P 500 and the Dow Jones Industrial Average r",
    "url": "https://finnhub.io/api/news?id=38558d276be5a29ce4312eef987aaaf167632e68a80d803eb4b0b4346318ad99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767823927,
      "headline": "S&P 500, Dow Jones Slid From Peaks Amid Sell-Off in Old Economy Sectors, Mounting Geopolitical Crisis",
      "id": 138033017,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "US equity indexes closed mixed on Wednesday, with the S&P 500 and the Dow Jones Industrial Average r",
      "url": "https://finnhub.io/api/news?id=38558d276be5a29ce4312eef987aaaf167632e68a80d803eb4b0b4346318ad99"
    }
  },
  {
    "ts": null,
    "headline": "Banking: M&A activity will see 'very rapid' boost in 2026",
    "summary": "Earnings season is kicking off for big banks — JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Morgan Stanley (MS), Wells Fargo (WFC), Goldman Sachs (GS) — throughout next week. Major US bank stocks notably ended 2025 at new record highs. Mendon Capital senior portfolio manager Anton Schutz explains how deregulation and M&A activity could present a promising environment for the banking sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finnhub.io/api/news?id=f740a8bde8cf7b18201c1c5fdfed949858678da43b52403d4fa8d587e7f24d95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767822657,
      "headline": "Banking: M&A activity will see 'very rapid' boost in 2026",
      "id": 138033018,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Earnings season is kicking off for big banks — JPMorgan Chase (JPM), Bank of America (BAC), Citigroup (C), Morgan Stanley (MS), Wells Fargo (WFC), Goldman Sachs (GS) — throughout next week. Major US bank stocks notably ended 2025 at new record highs. Mendon Capital senior portfolio manager Anton Schutz explains how deregulation and M&A activity could present a promising environment for the banking sector. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
      "url": "https://finnhub.io/api/news?id=f740a8bde8cf7b18201c1c5fdfed949858678da43b52403d4fa8d587e7f24d95"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan to replace Goldman as Apple Card issuer",
    "summary": "JPMorgan Chase and Apple on Wednesday announced a deal under which the bank will become the new issuer of the ​Apple Card, replacing Goldman Sachs, further expanding the biggest U.S. bank's credit ‌card franchise.  The deal would cement JPMorgan's position in the credit cards segment and mark another win for ‌CEO Jamie Dimon, under whose leadership the bank has become a dominant force in retail and investment banking.  The move is estimated to bring over $20 billion in card balances to Chase's platform once completed, the companies said.",
    "url": "https://finnhub.io/api/news?id=15fd76522c3da181cc27071e248fa9dafe05f31f399dd2349ca1f14dd6e776c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767821665,
      "headline": "JPMorgan to replace Goldman as Apple Card issuer",
      "id": 138032869,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan Chase and Apple on Wednesday announced a deal under which the bank will become the new issuer of the ​Apple Card, replacing Goldman Sachs, further expanding the biggest U.S. bank's credit ‌card franchise.  The deal would cement JPMorgan's position in the credit cards segment and mark another win for ‌CEO Jamie Dimon, under whose leadership the bank has become a dominant force in retail and investment banking.  The move is estimated to bring over $20 billion in card balances to Chase's platform once completed, the companies said.",
      "url": "https://finnhub.io/api/news?id=15fd76522c3da181cc27071e248fa9dafe05f31f399dd2349ca1f14dd6e776c3"
    }
  },
  {
    "ts": null,
    "headline": "Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations",
    "url": "https://finnhub.io/api/news?id=0184419225601116f5beea2b70ca0d44172b21ad78514baca051e8c546cb5e64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767821160,
      "headline": "Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138033020,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. PT on Wednesday, January 14, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will be accessible on the Investor Relations",
      "url": "https://finnhub.io/api/news?id=0184419225601116f5beea2b70ca0d44172b21ad78514baca051e8c546cb5e64"
    }
  },
  {
    "ts": null,
    "headline": "RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026",
    "url": "https://finnhub.io/api/news?id=d08813950da5275f3cbee0340f114374cda7e1d9f81308772724c7f21b679a48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819900,
      "headline": "RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138033023,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that Brian Wong, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 44thAnnual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026",
      "url": "https://finnhub.io/api/news?id=d08813950da5275f3cbee0340f114374cda7e1d9f81308772724c7f21b679a48"
    }
  },
  {
    "ts": null,
    "headline": "Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT. The live and archived webcast of the presen",
    "url": "https://finnhub.io/api/news?id=85b11099ccaf44a427a0e63ca53eee88ce9f45c24351eace189b6b6b1e8f46e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819900,
      "headline": "Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138033022,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's chief executive officer and president, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT. The live and archived webcast of the presen",
      "url": "https://finnhub.io/api/news?id=85b11099ccaf44a427a0e63ca53eee88ce9f45c24351eace189b6b6b1e8f46e7"
    }
  },
  {
    "ts": null,
    "headline": "Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST. A live webcast of the event can be accessed under",
    "url": "https://finnhub.io/api/news?id=43b85aab785679afa96428018b42df86afe8bb77038feb19852e88e739b352ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819900,
      "headline": "Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138033021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 11:15 a.m. PST. A live webcast of the event can be accessed under",
      "url": "https://finnhub.io/api/news?id=43b85aab785679afa96428018b42df86afe8bb77038feb19852e88e739b352ca"
    }
  },
  {
    "ts": null,
    "headline": "Bruker Corporation to Present at the J.P. Morgan Healthcare Conference",
    "summary": "BILLERICA, Mass., January 07, 2026--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time.",
    "url": "https://finnhub.io/api/news?id=92cd8a70c9b3a34ab74db927fa43b04b729548fd702f8ca462414bc3c4a4cf3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819660,
      "headline": "Bruker Corporation to Present at the J.P. Morgan Healthcare Conference",
      "id": 138033025,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BILLERICA, Mass., January 07, 2026--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 45th annual J.P. Morgan Healthcare Conference in San Francisco. Senior leadership will present on behalf of the Company on Monday, January 12th, 2026 at 9:00 AM Pacific Standard Time.",
      "url": "https://finnhub.io/api/news?id=92cd8a70c9b3a34ab74db927fa43b04b729548fd702f8ca462414bc3c4a4cf3d"
    }
  },
  {
    "ts": null,
    "headline": "Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours",
    "url": "https://finnhub.io/api/news?id=446a9ffd4e35eb04edd5fcfb8d8da18acba37eb589278f54457ef3578f4ed9d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819660,
      "headline": "Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138033024,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours",
      "url": "https://finnhub.io/api/news?id=446a9ffd4e35eb04edd5fcfb8d8da18acba37eb589278f54457ef3578f4ed9d3"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Financial Stocks Decline Late Afternoon",
    "summary": "Financial stocks were decreasing in late Wednesday trading, with the NYSE Financial Index down 1% an",
    "url": "https://finnhub.io/api/news?id=b312d8ee681e3123cc5026b19f2ff72c3b3a5c51ef026700fb9147a3898d1a5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819435,
      "headline": "Sector Update: Financial Stocks Decline Late Afternoon",
      "id": 138033026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Financial stocks were decreasing in late Wednesday trading, with the NYSE Financial Index down 1% an",
      "url": "https://finnhub.io/api/news?id=b312d8ee681e3123cc5026b19f2ff72c3b3a5c51ef026700fb9147a3898d1a5f"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer says investors should avoid buying stocks near their highs after the market's recent rally",
    "summary": "Jim Cramer warns investors not to chase stocks after big rallies, pointing to better entry points created by volatility and earnings season pullbacks.",
    "url": "https://finnhub.io/api/news?id=fc96a71ce565f979a25fcfde2e6544bf2b09cf99543ba11f17aaaee30561e7bc",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767812187,
      "headline": "Jim Cramer says investors should avoid buying stocks near their highs after the market's recent rally",
      "id": 138037769,
      "image": "https://image.cnbcfm.com/api/v1/image/107083447-1656625604715-IMG_2027rb.jpg?v=1695422550&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "Jim Cramer warns investors not to chase stocks after big rallies, pointing to better entry points created by volatility and earnings season pullbacks.",
      "url": "https://finnhub.io/api/news?id=fc96a71ce565f979a25fcfde2e6544bf2b09cf99543ba11f17aaaee30561e7bc"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Chase reaches deal to become Apple Card issuer as Goldman closes chapter on consumer foray",
    "summary": "JPMorgan Chase has reached a deal to take over the Apple credit card from Goldman Sachs, the two banks said late Wednesday.",
    "url": "https://finnhub.io/api/news?id=9ba0e37136d73631fbac2dfcb1b8750957ff3ead0e67d5daa7fb57d7a976f1c2",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767801800,
      "headline": "JPMorgan Chase reaches deal to become Apple Card issuer as Goldman closes chapter on consumer foray",
      "id": 138037823,
      "image": "https://image.cnbcfm.com/api/v1/image/108213165-1760638891276-gettyimages-2241014582-IMF_WORLD_BANK.jpeg?v=1760638927&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "JPMorgan Chase has reached a deal to take over the Apple credit card from Goldman Sachs, the two banks said late Wednesday. ",
      "url": "https://finnhub.io/api/news?id=9ba0e37136d73631fbac2dfcb1b8750957ff3ead0e67d5daa7fb57d7a976f1c2"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Stock Valuation is Underappreciating its Dominant Position, BofA Says",
    "summary": "JPMorgan Chase (JPM) stock valuation is underappreciating its dominant position underpinned by \"best",
    "url": "https://finnhub.io/api/news?id=8999256585b82dbd63bb49f0aa65dfa7ed99cc0e85ee931be30511623cd6f187",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767801397,
      "headline": "JPMorgan Stock Valuation is Underappreciating its Dominant Position, BofA Says",
      "id": 138027049,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan Chase (JPM) stock valuation is underappreciating its dominant position underpinned by \"best",
      "url": "https://finnhub.io/api/news?id=8999256585b82dbd63bb49f0aa65dfa7ed99cc0e85ee931be30511623cd6f187"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Chase Cuts Ties With Proxy Advisors, Launches AI Voting Tool",
    "summary": "The bank’s asset-management unit will ditch proxy advisors and use an internal AI tool to help with shareholder votes.",
    "url": "https://finnhub.io/api/news?id=70191a84e4d3c9c87f69670b8d7db0fe51c361d8af71e2642d8b9ec6f1aee25a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767795540,
      "headline": "JPMorgan Chase Cuts Ties With Proxy Advisors, Launches AI Voting Tool",
      "id": 138027050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The bank’s asset-management unit will ditch proxy advisors and use an internal AI tool to help with shareholder votes.",
      "url": "https://finnhub.io/api/news?id=70191a84e4d3c9c87f69670b8d7db0fe51c361d8af71e2642d8b9ec6f1aee25a"
    }
  },
  {
    "ts": null,
    "headline": "PostSig Launches Investor Rights Intelligence as Venture Firms Prepare for Aumni Sunset",
    "summary": "PostSig Replaces Static Portfolio Records With Continuous Investor Rights Intelligence SAN FRANCISCO, CA / ACCESS Newswire / January 7, 2026 / PostSig today announced the launch of itsInvestor Rights Intelligence solution, a new product designed to ...",
    "url": "https://finnhub.io/api/news?id=eadb6474edbb2065f8964c52e556f1031edb03e773ba3c4d1fd4eaa0bc838d17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767794400,
      "headline": "PostSig Launches Investor Rights Intelligence as Venture Firms Prepare for Aumni Sunset",
      "id": 138027052,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "PostSig Replaces Static Portfolio Records With Continuous Investor Rights Intelligence SAN FRANCISCO, CA / ACCESS Newswire / January 7, 2026 / PostSig today announced the launch of itsInvestor Rights Intelligence solution, a new product designed to ...",
      "url": "https://finnhub.io/api/news?id=eadb6474edbb2065f8964c52e556f1031edb03e773ba3c4d1fd4eaa0bc838d17"
    }
  },
  {
    "ts": null,
    "headline": "Masimo to Present in the J.P. Morgan 2026 Healthcare Conference",
    "summary": "IRVINE, Calif., January 07, 2026--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.",
    "url": "https://finnhub.io/api/news?id=ff2f03f540931f64823b2cdde66772514f396aeb5a0b504b6fa16375ff58f94a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767794400,
      "headline": "Masimo to Present in the J.P. Morgan 2026 Healthcare Conference",
      "id": 138027051,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "IRVINE, Calif., January 07, 2026--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.",
      "url": "https://finnhub.io/api/news?id=ff2f03f540931f64823b2cdde66772514f396aeb5a0b504b6fa16375ff58f94a"
    }
  },
  {
    "ts": null,
    "headline": "J.P. Morgan’s JPM Coin set for native issuance on Canton blockchain",
    "summary": "Investing.com-- Digital Asset and Kinexys by J.P. Morgan said Wednesday they intend to collaborate on bringing J.P. Morgan’s U.S. dollar deposit token, JPM Coin (ticker: JPMD), natively onto the Canton Network, marking another step toward deploying regulated digital money on blockchain infrastructure built for institutional use.",
    "url": "https://finnhub.io/api/news?id=f0789ebcf0336fd7d72a8d845b819245771a974b37e9ba3eb227fce6d669618d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767792602,
      "headline": "J.P. Morgan’s JPM Coin set for native issuance on Canton blockchain",
      "id": 138027053,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Investing.com-- Digital Asset and Kinexys by J.P. Morgan said Wednesday they intend to collaborate on bringing J.P. Morgan’s U.S. dollar deposit token, JPM Coin (ticker: JPMD), natively onto the Canton Network, marking another step toward deploying regulated digital money on blockchain infrastructure built for institutional use.",
      "url": "https://finnhub.io/api/news?id=f0789ebcf0336fd7d72a8d845b819245771a974b37e9ba3eb227fce6d669618d"
    }
  },
  {
    "ts": null,
    "headline": "Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET. A",
    "url": "https://finnhub.io/api/news?id=0db695c9c3846ff4470026d264a1eff38df3d54ad3488316a9faf9f0a88471f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767792600,
      "headline": "Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027054,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WATERTOWN, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that John Quisel, J.D., Ph.D., President and Chief Executive Officer, will give a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th at 3:00 pm PT / 6:00 pm ET. A",
      "url": "https://finnhub.io/api/news?id=0db695c9c3846ff4470026d264a1eff38df3d54ad3488316a9faf9f0a88471f3"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan’s Kinexys Expands Digital Payments Push With Canton Network Partnership",
    "summary": "JPMorgan Chase’s blockchain unit Kinexys has announced on Tuesday it plans to bring its deposit token JPM Coin (JPMD) natively onto the Canton Network.The collaboration, unveiled in early 2026 alongside Digital Asset aims to allow the issuance, transfer and redemption of JPM Coin directly on Canton’s blockchain infrastructure. The move ...",
    "url": "https://finnhub.io/api/news?id=8b6ebc39cdcae93ef36622740570a3b39e5e99fa4cc5ac269848d9b343b56dc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767791009,
      "headline": "JPMorgan’s Kinexys Expands Digital Payments Push With Canton Network Partnership",
      "id": 138027055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan Chase’s blockchain unit Kinexys has announced on Tuesday it plans to bring its deposit token JPM Coin (JPMD) natively onto the Canton Network.The collaboration, unveiled in early 2026 alongside Digital Asset aims to allow the issuance, transfer and redemption of JPM Coin directly on Canton’s blockchain infrastructure. The move ...",
      "url": "https://finnhub.io/api/news?id=8b6ebc39cdcae93ef36622740570a3b39e5e99fa4cc5ac269848d9b343b56dc7"
    }
  },
  {
    "ts": null,
    "headline": "Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finnhub.io/api/news?id=ae84003d8bb961392d858d4de91dd61f2c994ec5ee2d558ab98f5a883c7face1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790800,
      "headline": "Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027060,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
      "url": "https://finnhub.io/api/news?id=ae84003d8bb961392d858d4de91dd61f2c994ec5ee2d558ab98f5a883c7face1"
    }
  },
  {
    "ts": null,
    "headline": "Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco from January 12 to 15, 2026. Mike Andriole, Artios’ Chief Executive Officer, will highlight the company’s strategic priorities for its two differentiated, pote",
    "url": "https://finnhub.io/api/news?id=f23203ed81f43860730880d8df868c1d022c74f6f12c0adbb149faa1f153e374",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790800,
      "headline": "Artios to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, United Kingdom and NEW YORK, January 7, 2026 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (“DDR”) in cancer, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco from January 12 to 15, 2026. Mike Andriole, Artios’ Chief Executive Officer, will highlight the company’s strategic priorities for its two differentiated, pote",
      "url": "https://finnhub.io/api/news?id=f23203ed81f43860730880d8df868c1d022c74f6f12c0adbb149faa1f153e374"
    }
  },
  {
    "ts": null,
    "headline": "Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 pm PT in San Francisco. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protar",
    "url": "https://finnhub.io/api/news?id=5e77a464c662f3241b590e25c879600f21ef79772d39570f32f0bb9b6cab389c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790800,
      "headline": "Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 pm PT in San Francisco. A live webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protar",
      "url": "https://finnhub.io/api/news?id=5e77a464c662f3241b590e25c879600f21ef79772d39570f32f0bb9b6cab389c"
    }
  },
  {
    "ts": null,
    "headline": "Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences",
    "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday, January 14, 2026. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of t",
    "url": "https://finnhub.io/api/news?id=e2bc718cba9ff63ee6edd98d94b823e81a2851088893f90567bc5a231a4a8b45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790800,
      "headline": "Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences",
      "id": 138027057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday, January 14, 2026. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of t",
      "url": "https://finnhub.io/api/news?id=e2bc718cba9ff63ee6edd98d94b823e81a2851088893f90567bc5a231a4a8b45"
    }
  },
  {
    "ts": null,
    "headline": "Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
    "summary": "GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent’s session may be accessed here and will be live for up to 30 days. The Company’s slides will be made available at the time of the presentation on the Investors section of",
    "url": "https://finnhub.io/api/news?id=a92b06d8f18f73039ac1b02dbb9e74e713b919c54e0320c14de83c71d2906294",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790740,
      "headline": "Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
      "id": 138027061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent’s session may be accessed here and will be live for up to 30 days. The Company’s slides will be made available at the time of the presentation on the Investors section of",
      "url": "https://finnhub.io/api/news?id=a92b06d8f18f73039ac1b02dbb9e74e713b919c54e0320c14de83c71d2906294"
    }
  },
  {
    "ts": null,
    "headline": "Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 5:15 p.m. PT (8:15 p.m. ET). A live webcast will be available in the Investor",
    "url": "https://finnhub.io/api/news?id=43d9d2790d378585d7f0bb0324f94a3ad5f701f4e03bd1bb6d29be3915b0e2ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767789000,
      "headline": "Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 5:15 p.m. PT (8:15 p.m. ET). A live webcast will be available in the Investor",
      "url": "https://finnhub.io/api/news?id=43d9d2790d378585d7f0bb0324f94a3ad5f701f4e03bd1bb6d29be3915b0e2ed"
    }
  },
  {
    "ts": null,
    "headline": "TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Presentation scheduled for Tuesday, January 13, 2026, at 1:30 PM PSTNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Tuesday, January 13, 2026, at 1:30 PM PST. A live webcast of this presentation will be available on the Events page, located within the Investors",
    "url": "https://finnhub.io/api/news?id=05b9344bce74943f5ebaf46bb47b262ed002b04cdd813c532eb614116cfd134f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767789000,
      "headline": "TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138027063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Presentation scheduled for Tuesday, January 13, 2026, at 1:30 PM PSTNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled to take place on Tuesday, January 13, 2026, at 1:30 PM PST. A live webcast of this presentation will be available on the Events page, located within the Investors",
      "url": "https://finnhub.io/api/news?id=05b9344bce74943f5ebaf46bb47b262ed002b04cdd813c532eb614116cfd134f"
    }
  },
  {
    "ts": null,
    "headline": "Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026",
    "summary": "NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. (\"Protagonist\" or the \"Company\") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual ...",
    "url": "https://finnhub.io/api/news?id=ce8644dd58a029cdd5400ecdc4839bd29a8f823f4608017416f2abe587a70240",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767789000,
      "headline": "Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026",
      "id": 138027062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. (\"Protagonist\" or the \"Company\") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the 44th Annual ...",
      "url": "https://finnhub.io/api/news?id=ce8644dd58a029cdd5400ecdc4839bd29a8f823f4608017416f2abe587a70240"
    }
  },
  {
    "ts": null,
    "headline": "BAC Shares Outpace the S&P 500 in 2025: Will Momentum Hold in 2026?",
    "summary": "BAC jumps 24.1% in 2025, beating the S&P 500 again. Will loan growth, branch expansion and a strong balance sheet keep the rally alive in 2026? Let's decipher.",
    "url": "https://finnhub.io/api/news?id=eaf34560cf328e093df5597fbe7dd88d43173ce76af16e50ef41607b36010566",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787500,
      "headline": "BAC Shares Outpace the S&P 500 in 2025: Will Momentum Hold in 2026?",
      "id": 138027066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BAC jumps 24.1% in 2025, beating the S&P 500 again. Will loan growth, branch expansion and a strong balance sheet keep the rally alive in 2026? Let's decipher.",
      "url": "https://finnhub.io/api/news?id=eaf34560cf328e093df5597fbe7dd88d43173ce76af16e50ef41607b36010566"
    }
  },
  {
    "ts": null,
    "headline": "The biggest market risk in 2026 is the one no one talks about",
    "summary": "Deal activity is heating up amid lower interest rates from the Fed and a sense from sellers that valuations are about as full as one could expect. Yahoo Finance executive editor Brian Sozzi sits down on the Opening Bid Unfiltered podcast with Apollo Global Management co-head of equity David Sambur. After being held by Liberation Day market related volatility, the environment for deal-making has picked up. 2025 was poised to become the second highest in deal activity, up 36% in value to an estimated $4.8 trillion according to Bain & Company. Megadeals greater than $5 billion represented more than 75% of incremental deal value. Meanwhile, exit activity for private equity companies accelerated meaningfully in the third quarter of last year. Private equity firms announced exits totaling $470 billion in 2025 per the latest data from EY, marking a 40% increase by value compared with the same period last year. Sambur shares his outlook for M&A and exits in 2026, the drivers of that potential activity and what he has learned from making big deals over the course of his career.Disclosure: Yahoo is a portfolio company of funds managed by affiliates of Apollo Global Management.",
    "url": "https://finnhub.io/api/news?id=03c37c1d149463a938535987354669c398087af8e6aec344e6f066a1504e9b7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787253,
      "headline": "The biggest market risk in 2026 is the one no one talks about",
      "id": 138025972,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Deal activity is heating up amid lower interest rates from the Fed and a sense from sellers that valuations are about as full as one could expect. Yahoo Finance executive editor Brian Sozzi sits down on the Opening Bid Unfiltered podcast with Apollo Global Management co-head of equity David Sambur. After being held by Liberation Day market related volatility, the environment for deal-making has picked up. 2025 was poised to become the second highest in deal activity, up 36% in value to an estimated $4.8 trillion according to Bain & Company. Megadeals greater than $5 billion represented more than 75% of incremental deal value. Meanwhile, exit activity for private equity companies accelerated meaningfully in the third quarter of last year. Private equity firms announced exits totaling $470 billion in 2025 per the latest data from EY, marking a 40% increase by value compared with the same period last year. Sambur shares his outlook for M&A and exits in 2026, the drivers of that potential activity and what he has learned from making big deals over the course of his career.Disclosure: Yahoo is a portfolio company of funds managed by affiliates of Apollo Global Management.",
      "url": "https://finnhub.io/api/news?id=03c37c1d149463a938535987354669c398087af8e6aec344e6f066a1504e9b7d"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan Cuts All Ties With Proxy Advisers in Industry First",
    "summary": "The bank’s asset-management unit will use an in-house, AI-powered platform to cast shareholder votes.",
    "url": "https://finnhub.io/api/news?id=ed4b6c63eb46b77b60aedf6a485a25036d82ae9663303adabe579ab47b55c1eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787200,
      "headline": "JPMorgan Cuts All Ties With Proxy Advisers in Industry First",
      "id": 138027068,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The bank’s asset-management unit will use an in-house, AI-powered platform to cast shareholder votes.",
      "url": "https://finnhub.io/api/news?id=ed4b6c63eb46b77b60aedf6a485a25036d82ae9663303adabe579ab47b55c1eb"
    }
  },
  {
    "ts": null,
    "headline": "Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that Chris Varma, Ph.D., co-founder, chair, and chief executive officer of Frontier Medicines, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:30",
    "url": "https://finnhub.io/api/news?id=5d2c6f72390adc6217728e630ff082a33e9921a8e3c2cbbb8369b0d9d7fd1318",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787200,
      "headline": "Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138025804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that Chris Varma, Ph.D., co-founder, chair, and chief executive officer of Frontier Medicines, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:30",
      "url": "https://finnhub.io/api/news?id=5d2c6f72390adc6217728e630ff082a33e9921a8e3c2cbbb8369b0d9d7fd1318"
    }
  },
  {
    "ts": null,
    "headline": "LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BALLERUP, Denmark, January 07, 2026--LEO Pharma CEO Christophe Bourdon will give a company update at the J.P. Morgan Healthcare Conference in San Francisco on January 13 at 9:00 AM PST",
    "url": "https://finnhub.io/api/news?id=8c074daf813233dca609ca87cac4fe9c8b75a340623116c4ec656f8bebecec97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787200,
      "headline": "LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138025803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BALLERUP, Denmark, January 07, 2026--LEO Pharma CEO Christophe Bourdon will give a company update at the J.P. Morgan Healthcare Conference in San Francisco on January 13 at 9:00 AM PST",
      "url": "https://finnhub.io/api/news?id=8c074daf813233dca609ca87cac4fe9c8b75a340623116c4ec656f8bebecec97"
    }
  },
  {
    "ts": null,
    "headline": "Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 07, 2026--Stylus Medicine, Inc. (\"Stylus\"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT.",
    "url": "https://finnhub.io/api/news?id=7900769c7c94bf2f60abc4777c4c92abeb135c3b5aa15c195b57a117597e7eb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787200,
      "headline": "Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 138025802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., January 07, 2026--Stylus Medicine, Inc. (\"Stylus\"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced that Emile Nuwaysir, Ph.D., chairman and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 5:00 p.m. PT.",
      "url": "https://finnhub.io/api/news?id=7900769c7c94bf2f60abc4777c4c92abeb135c3b5aa15c195b57a117597e7eb1"
    }
  },
  {
    "ts": null,
    "headline": "Brokerages Raise TSMC Targets After Strong Start to 2026",
    "summary": "At least six firms lift projections as JPMorgan hikes its target 24% to NT$2,100 ahead of earnings.",
    "url": "https://finnhub.io/api/news?id=03171ebfb9ed5c5e4bc0ee37240a32d3bcad284850003b5d3cdf85cbdacd6637",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767787127,
      "headline": "Brokerages Raise TSMC Targets After Strong Start to 2026",
      "id": 138025805,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "At least six firms lift projections as JPMorgan hikes its target 24% to NT$2,100 ahead of earnings.",
      "url": "https://finnhub.io/api/news?id=03171ebfb9ed5c5e4bc0ee37240a32d3bcad284850003b5d3cdf85cbdacd6637"
    }
  },
  {
    "ts": null,
    "headline": "5 Bold Market Predictions For 2026",
    "summary": "5 bold 2026 market predictions: AI-driven gains, major IPOs, and stretched valuations.",
    "url": "https://finnhub.io/api/news?id=1c925addedae350535cde385175b13c37c4476ffedd681948bcf7c06baafcaef",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767785200,
      "headline": "5 Bold Market Predictions For 2026",
      "id": 138027710,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2229908008/image_2229908008.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "5 bold 2026 market predictions: AI-driven gains, major IPOs, and stretched valuations.",
      "url": "https://finnhub.io/api/news?id=1c925addedae350535cde385175b13c37c4476ffedd681948bcf7c06baafcaef"
    }
  },
  {
    "ts": null,
    "headline": "Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference",
    "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, ...",
    "url": "https://finnhub.io/api/news?id=c70e1f4d1263a86950bd36799d6e11445d685c1aa54b6b925e5c57df872dfe11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767783600,
      "headline": "Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference",
      "id": 138025806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, ...",
      "url": "https://finnhub.io/api/news?id=c70e1f4d1263a86950bd36799d6e11445d685c1aa54b6b925e5c57df872dfe11"
    }
  },
  {
    "ts": null,
    "headline": "JPMorganChase Survey: U.S. Business Leaders Signal Optimism and Growth Plans for 2026 Despite Economic Uncertainty",
    "summary": "NEW YORK, January 07, 2026--At the start of the year, strong optimism among U.S. business leaders is setting the stage for an active 2026, according to JPMorganChase’s annual Business Leaders Outlook survey of small and midsize companies. Following a year of persistent economic and geopolitical headwinds, business leaders are charting a path forward by pursuing growth opportunities, embracing emerging technologies and, in some cases, forging new strategic partnerships.",
    "url": "https://finnhub.io/api/news?id=ee93fa0c416fb5ab7f065deebaa8dc541cc975686ce40fa2e9a547ecda7a385f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767780180,
      "headline": "JPMorganChase Survey: U.S. Business Leaders Signal Optimism and Growth Plans for 2026 Despite Economic Uncertainty",
      "id": 138025807,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NEW YORK, January 07, 2026--At the start of the year, strong optimism among U.S. business leaders is setting the stage for an active 2026, according to JPMorganChase’s annual Business Leaders Outlook survey of small and midsize companies. Following a year of persistent economic and geopolitical headwinds, business leaders are charting a path forward by pursuing growth opportunities, embracing emerging technologies and, in some cases, forging new strategic partnerships.",
      "url": "https://finnhub.io/api/news?id=ee93fa0c416fb5ab7f065deebaa8dc541cc975686ce40fa2e9a547ecda7a385f"
    }
  },
  {
    "ts": null,
    "headline": "America's midsize businesses express 'cautious optimism' for 2026 after exuberant 2025: JPMorgan survey",
    "summary": "JPMorgan's latest survey of America's middle-market businesses shows some \"cautious optimism\" as 2026 gets underway after enthusiasm ran high a year ago.",
    "url": "https://finnhub.io/api/news?id=d09caacd854c61fdad5f92a5cbd16f49a07977adf810d2121bcf74834c169d5b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767780028,
      "headline": "America's midsize businesses express 'cautious optimism' for 2026 after exuberant 2025: JPMorgan survey",
      "id": 138025808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "JPMorgan's latest survey of America's middle-market businesses shows some \"cautious optimism\" as 2026 gets underway after enthusiasm ran high a year ago.",
      "url": "https://finnhub.io/api/news?id=d09caacd854c61fdad5f92a5cbd16f49a07977adf810d2121bcf74834c169d5b"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan's asset management will no longer use controversial proxy advisors for shareholder votes",
    "summary": "JPMorgan said it is instead using artificial intelligence to aggregate and analyze proxy data.",
    "url": "https://finnhub.io/api/news?id=cfc2a375085c2e23611121f47165b75363e10e522b2d04d0d83822eafaabba14",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767777555,
      "headline": "JPMorgan's asset management will no longer use controversial proxy advisors for shareholder votes",
      "id": 138027984,
      "image": "https://image.cnbcfm.com/api/v1/image/108222459-17624473522025-11-06t164139z_76535834_rc23rhatub8c_rtrmadp_0_usa-abf.jpeg?v=1762447485&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "JPMorgan said it is instead using artificial intelligence to aggregate and analyze proxy data.",
      "url": "https://finnhub.io/api/news?id=cfc2a375085c2e23611121f47165b75363e10e522b2d04d0d83822eafaabba14"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
    "summary": "The stock market was little changed this morning after the S&P 500 hit records highs Tuesday.",
    "url": "https://finnhub.io/api/news?id=a57b975de029806c09eb01c4b7ec39385868263fc9dfb7e3d6ee1aa602c63b5b",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767777423,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
      "id": 138027947,
      "image": "https://image.cnbcfm.com/api/v1/image/107200469-1677528554271-NUP_200782_00155.jpg?v=1721682202&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "The stock market was little changed this morning after the S&P 500 hit records highs Tuesday.",
      "url": "https://finnhub.io/api/news?id=a57b975de029806c09eb01c4b7ec39385868263fc9dfb7e3d6ee1aa602c63b5b"
    }
  },
  {
    "ts": null,
    "headline": "How JPMorgan CEO Jamie Dimon notched $770 million in gains for his work in 2025",
    "summary": "Dimon has accumulated a lot of equity through his compensation plan, personal purchases, and via a 2021 special award.",
    "url": "https://finnhub.io/api/news?id=4a67270ea957a9fd3738371385a1189e7089976528189f763c13d31a51aa7c90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767774180,
      "headline": "How JPMorgan CEO Jamie Dimon notched $770 million in gains for his work in 2025",
      "id": 138025809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Dimon has accumulated a lot of equity through his compensation plan, personal purchases, and via a 2021 special award.",
      "url": "https://finnhub.io/api/news?id=4a67270ea957a9fd3738371385a1189e7089976528189f763c13d31a51aa7c90"
    }
  },
  {
    "ts": null,
    "headline": "Bond Market Signals Go-Ahead For Bank Stocks with JP Morgan Earnings On Deck",
    "summary": "A steeper yield curve and strong deal activity are lifting bank stocks ahead of JPMorgan’s earnings, with analysts expecting financials to drive a fifth of S&P 500 profits.",
    "url": "https://finnhub.io/api/news?id=8931ae70418d0e844bb7b302369810a52d565a16612439455da8dc5308fc8781",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767769200,
      "headline": "Bond Market Signals Go-Ahead For Bank Stocks with JP Morgan Earnings On Deck",
      "id": 138025810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "A steeper yield curve and strong deal activity are lifting bank stocks ahead of JPMorgan’s earnings, with analysts expecting financials to drive a fifth of S&P 500 profits.",
      "url": "https://finnhub.io/api/news?id=8931ae70418d0e844bb7b302369810a52d565a16612439455da8dc5308fc8781"
    }
  },
  {
    "ts": null,
    "headline": "Is JPMorgan Chase (JPM) Fairly Priced After Big Gains And Capital Rule Headlines",
    "summary": "If you are wondering whether JPMorgan Chase is still fairly priced after a strong run, this article walks through what the current share price could imply about value. With the stock at US$334.61, recent returns of 3.5% over 7 days, 6.2% over 30 days, 2.8% year to date, 40.4% over 1 year, 159.2% over 3 years and 171.0% over 5 years put the current price in clear focus for investors thinking about upside and risk. Recent headlines around large US banks have centered on capital requirements...",
    "url": "https://finnhub.io/api/news?id=4199431496816f1d59f962a51c4a566b70ab590829d3aee512a8d23e0e4e9508",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767762565,
      "headline": "Is JPMorgan Chase (JPM) Fairly Priced After Big Gains And Capital Rule Headlines",
      "id": 138022674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "If you are wondering whether JPMorgan Chase is still fairly priced after a strong run, this article walks through what the current share price could imply about value. With the stock at US$334.61, recent returns of 3.5% over 7 days, 6.2% over 30 days, 2.8% year to date, 40.4% over 1 year, 159.2% over 3 years and 171.0% over 5 years put the current price in clear focus for investors thinking about upside and risk. Recent headlines around large US banks have centered on capital requirements...",
      "url": "https://finnhub.io/api/news?id=4199431496816f1d59f962a51c4a566b70ab590829d3aee512a8d23e0e4e9508"
    }
  },
  {
    "ts": null,
    "headline": "Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies",
    "summary": "The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (\"Kelun-Biotech\" or the \"Company\", 6990.HK) has been invited to attend the conference and Dr. Michael Ge, President and CEO of Kelun-Biotech, will share the company's latest business progresses as well as its innovation capabilities and strategies.",
    "url": "https://finnhub.io/api/news?id=6582ddf3b95e86770335234ab85a7becec69406f60a16e41f3aee3b10dd95ca7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767753840,
      "headline": "Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies",
      "id": 138022675,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (\"Kelun-Biotech\" or the \"Company\", 6990.HK) has been invited to attend the conference and Dr. Michael Ge, President and CEO of Kelun-Biotech, will share the company's latest business progresses as well as its innovation capabilities and strategies.",
      "url": "https://finnhub.io/api/news?id=6582ddf3b95e86770335234ab85a7becec69406f60a16e41f3aee3b10dd95ca7"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Stocks If a Recession Is Coming in 2026? Here's What History Shows.",
    "summary": "The past reveals both good and bad news for investors.",
    "url": "https://finnhub.io/api/news?id=9ecbd93b29518138529ea4f2ffa43a518a19dcd72e9718a7cbceae1fd7df132c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767744240,
      "headline": "Should You Buy Stocks If a Recession Is Coming in 2026? Here's What History Shows.",
      "id": 138022676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The past reveals both good and bad news for investors.",
      "url": "https://finnhub.io/api/news?id=9ecbd93b29518138529ea4f2ffa43a518a19dcd72e9718a7cbceae1fd7df132c"
    }
  }
]